Evidence map›Paper›PMID 24683306›Full record

ReviewThe application of clinical genetics2014

Genetics of bipolar disorder.

Berit Kerner

Open access · goldAbstract readReview
In one paragraph

Review in The application of clinical genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 110 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Machine Learning Techniques to Predict Mental Health Diagnoses: A Systematic Literature Review.Clinical practice and epidemiology in mental health : CP & EMH · 2024
    Review
  7. Article
  8. Article
  9. Comments on intron 4 VNTR polymorphism in theNeurosciences (Riyadh, Saudi Arabia) · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Antioxidative Defense Genes and Brain Structure in Youth Bipolar Disorder.The international journal of neuropsychopharmacology · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Berit KernerSemel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA, USA.
University of California, Los Angeles · US

Funding

Symptom Dimensions in PsychosisK08MH074057 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KERNER, BERIT · 2005 to 2009
$872k
Parsing of Bipolar Disorders and Schizophrenia: A Latent Class ApproachR01MH085744 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KERNER, BERIT · 2010 to 2012
$723k
NIMH NIH HHS K08 MH074057NIMH NIH HHS R01 MH085744
6 · The paper itself

Abstract

Bipolar disorder is a common, complex genetic disorder, but the mode of transmission remains to be discovered. Many researchers assume that common genomic variants carry some risk for manifesting the disease. The research community has celebrated the first genome-wide significant associations between common single nucleotide polymorphisms (SNPs) and bipolar disorder. Currently, attempts are under way to translate these findings into clinical practice, genetic counseling, and predictive testing. However, some experts remain cautious. After all, common variants explain only a very small percentage of the genetic risk, and functional consequences of the discovered SNPs are inconclusive. Furthermore, the associated SNPs are not disease specific, and the majority of individuals with a "risk" allele are healthy. On the other hand, population-based genome-wide studies in psychiatric disorders have rediscovered rare structural variants and mutations in genes, which were previously known to cause genetic syndromes and monogenic Mendelian disorders. In many Mendelian syndromes, psychiatric symptoms are prevalent. Although these conditions do not fit the classic description of any specific psychiatric disorder, they often show nonspecific psychiatric symptoms that cross diagnostic boundaries, including intellectual disability, behavioral abnormalities, mood disorders, anxiety disorders, attention deficit, impulse control deficit, and psychosis. Although testing for chromosomal disorders and monogenic Mendelian disorders is well established, testing for common variants is still controversial. The standard concept of genetic testing includes at least three broad criteria that need to be fulfilled before new genetic tests should be introduced: analytical validity, clinical validity, and clinical utility. These criteria are currently not fulfilled for common genomic variants in psychiatric disorders. Further work is clearly needed before genetic testing for common variants in psychiatric disorders should be established.

Indexed as

bipolar disordergenetic testinggenomic variantsMendelian disordersrisk factorsstructural variants

Identifiers

PMID24683306
PMCPMC3966627
OpenAlexW1988470405

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.